200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 16562-14-4

16562-14-4

16562-14-4 | 6H-Dibenzo[a,g]quinolizine-2,10-diol, 5,8,13,13a-tetrahydro-3,9-dimethoxy-

CAS No: 16562-14-4 Catalog No: AG001W9F MDL No:

Product Description

Catalog Number:
AG001W9F
Chemical Name:
6H-Dibenzo[a,g]quinolizine-2,10-diol, 5,8,13,13a-tetrahydro-3,9-dimethoxy-
CAS Number:
16562-14-4
Molecular Formula:
C19H21NO4
Molecular Weight:
327.3743
IUPAC Name:
3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol
InChI:
InChI=1S/C19H21NO4/c1-23-18-8-12-5-6-20-10-14-11(3-4-16(21)19(14)24-2)7-15(20)13(12)9-17(18)22/h3-4,8-9,15,21-22H,5-7,10H2,1-2H3
InChI Key:
JKPISQIIWUONPB-UHFFFAOYSA-N
SMILES:
COc1cc2CCN3C(c2cc1O)Cc1c(C3)c(OC)c(cc1)O

Properties

Complexity:
447  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
327.147g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
327.38g/mol
Monoisotopic Mass:
327.147g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
62.2A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6  

Literature

Title Journal
l-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT(1A) receptor partial agonistic activity. Synapse (New York, N.Y.) 20110501
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiology of aging 20100601
Enantioselective total synthesis of (-)-(S)-stepholidine. The Journal of organic chemistry 20091204
D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacology, biochemistry, and behavior 20091101
Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand. Schizophrenia research 20091101
Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D(1) and antagonist at D(2) receptors, in rats. British journal of pharmacology 20091101
[Five alkaloids from vine stems of Diploclisia affinis]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20081101
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology 20080801
Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cellular and molecular neurobiology 20080601
Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. British journal of cancer 20080129
Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations. Biophysical journal 20070901
Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS & neurological disorders drug targets 20070801
Effects of (-)-stepholidine on NMDA receptors: comparison with haloperidol and clozapine. Acta pharmacologica Sinica 20070701
Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
l-Stepholidine increases the frequency of sEPSC via the activation of D1 dopamine signaling pathway in rat prelimbic cortical neurons. Acta pharmacologica Sinica 20070501
The effect of L-stepholidine, a novel extract of Chinese herb, on the acquisition, expression, maintenance, and re-acquisition of morphine conditioned place preference in rats. Neuropharmacology 20070201
Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications. Current medicinal chemistry 20070101
Effects of (-)stepholidine in animal models for schizophrenia. Acta pharmacologica Sinica 20060901
Acetylcholinesterase inhibitors from Stephania venosa tuber. The Journal of pharmacy and pharmacology 20060501
Stepholidine protects against H2O2 neurotoxicity in rat cortical neurons by activation of Akt. Neuroscience letters 20050805
Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050201
Recent pharmacological studies on natural products in China. European journal of pharmacology 20041001
Miscellaneous treatments for neuroleptic-induced tardive dyskinesia. The Cochrane database of systematic reviews 20030101
(-)-Stepholidine promotes proliferation and neuronal differentiation of rat embryonic striatal precursor cells in vitro. Neuroreport 20021115
(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends in pharmacological sciences 20020101

© 2019 Angene International Limited. All rights Reserved.